Rivarp Medical Pvt., Ltd. appears in FDA device records as the applicant for Kentrospine pedicle screw systems, a posterior spinal fixation family intended for spinal stabilization and fusion alongside compatible instruments. The company’s own published pages describe research, manufacturing and distribution of medical devices and implants, with activity in spine, cardiology and neurology. The documented regulatory footprint in the linked records is narrow: one 510(k) entry, K252139, decided substantially equivalent on September 27, 2026. That single linked record is a snapshot of the filings assembled here, not a measure of total portfolio, sales or safety performance. [1][2][6]
Documented spine systems and components
The Kentrospine PSS Pedicle Screw System is described in its instructions for use as a top-loading, multiple-component posterior spinal fixation system. Listed components include monoaxial, polyaxial, dual core, reduction and fenestrated pedicle screws, PSS rods, a PSS locking cap and PSS cross linking connectors. The same document states that the system allows surgeons to build a spinal implant construct to stabilize and promote spinal fusion. [7]
A 2022 FDA clearance letter for K220486 identifies the Kentrospine PSS Pedicle Screw System as a Class II thoracolumbosacral pedicle screw system under 21 CFR 888.3070 and product code NKB, reviewed by the Orthopedic panel. The letter lists PSS monoaxial and polyaxial pedicle screws, locking cap, crosslink connector and rod among the system’s components, and names the CD HORIZON Spinal System (K091442) as the primary predicate. [5]
The 2026 Viktr-MIS filing
FDA records for K252139 identify the Kentrospine Viktr-MIS® Pedicle screw system, submitted by Rivarp Medical Pvt., Ltd. under product code NKB. The record shows a Traditional 510(k) received July 8, 2025, with a decision of substantially equivalent (SESE) dated September 27, 2026, and a summary statement. The review advisory committee is listed as Orthopedic. [1]
An Innolitics third-party index of the same submission describes the Viktr-MIS system as a posterior spinal fixation system used with compatible instruments. It lists the PathLoc-L MIS Spinal System (K183117) as the primary predicate under product code NKB. [6]
Company statements and quality documentation
Rivarp Medical’s published About page states that the decade-old company is engaged in research, manufacturing and distribution of medical devices and implants designed to meet international standards, and that it brings products to Indian markets under the Government of India’s Make in India initiative. The same page names Sushma N.R as Director Regulatory Affairs & QA/QC and Madhusudan Vadeyar as General Manager Supply Chain & Corporate Communications. [2]
The company’s home page states that Rivarp is accredited by BSI to ISO 13485:2016 and 9001:2015 and that its manufacturing facility is approved for Class A, B, C and D medical devices by CDSCO. These are manufacturer-published claims; the linked FDA records do not independently confirm them. The company lists a Bengaluru address on Mysore Road, which also appears as the applicant address in FDA correspondence. [3][5]
Filing scope and how to read the record
The linked collection contains one 510(k) record, K252139, with a decision count of one SESE; the explicitly smaller record sample likewise contains that single entry. These figures describe the assembled filings as of the snapshot date and should not be read as total company submissions, commercial availability or clinical performance. The 2022 K220486 letter is a separate FDA document and is not part of that linked collection count. [1][5]
Rivarp’s surgical technique page states that Kentrospine technique guides are sent on request and directs users to follow the instructions for use supplied with the device and to check the IFU revision against the product label. The company’s site also lists spine categories including thoraco-lumbar fixation, lumbar interbody, cervical, and vertebral body and column. [4]

